Home / Products / Cancer (Tumor) Cell Lines / SU-DHL-2
SU-DHL-2
Datasheet Protocol

SU-DHL-2

Cat. No. ARC0897
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Pleural effusion

Growth Properties:

Suspension

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

SU-DHL-2 is a cancer cell line of pleural effusion diffuse large B cell lymphoma, isolated from in situ; pleural effusion.

Recommended Products

FGD1 Knockout HT29 Polyclonal Cells FGD1 Knockout HT29 Polyclonal Cells Cat. No. ARG14843 LGALS1 Knockout A549 Polyclonal Cells LGALS1 Knockout A549 Polyclonal Cells Cat. No. ARG10964 AGPS Knockout NCI-H1975 Polyclonal Cells AGPS Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG31062 HSD17B11 Knockout A549 Polyclonal Cells HSD17B11 Knockout A549 Polyclonal Cells Cat. No. ARG33757 KHK Knockout HCT116 Polyclonal Cells KHK Knockout HCT116 Polyclonal Cells Cat. No. ARG34843 NBEAL2 Knockout Raji Polyclonal Cells NBEAL2 Knockout Raji Polyclonal Cells Cat. No. ARG1241
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Pleural effusion
Disease:
Diffuse large B cell lymphoma
Morphology:
Lymphoblast-like
Growth Mode:
Suspension
Age:
73 years
Sex of Donor:
Female
Derived From Site:
In situ; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

GPRIN3 Knockout Raji Polyclonal Cells

GPRIN3 Knockout Raji Polyclonal Cells

Cat. No. ARG23620
 ABCD4 Knockout NCI-H1299 Polyclonal Cells

ABCD4 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG30161
 BAD Knockout DLD-1 Polyclonal Cells

BAD Knockout DLD-1 Polyclonal Cells

Cat. No. ARG35516
 KNTC1 Knockout HEK293T Polyclonal Cells

KNTC1 Knockout HEK293T Polyclonal Cells

Cat. No. ARG38036
 PARP1 Knockout Raji Polyclonal Cells

PARP1 Knockout Raji Polyclonal Cells

Cat. No. ARG1382
 Npc1 Knockout MIN6 Cell Line

Npc1 Knockout MIN6 Cell Line

Cat. No. ARG0584